PharmAbcine
Latest round
- Series G
Last raised
- Feb 2018
Total raised
- $25M
Investors
- 17
About PharmAbcine
Based in Daejeon, South Korea, and founded in 2008, PharmAbcine is a specialized biotech company that develops fully human therapeutic monoclonal antibodies (mAb) using innovative discovery technology and excellent human resources for the treatment of human diseases, such as cancer and inflammatory diseases. It also offers antibody panning services. In December 2009, the company established an R&D Center. The company was nominated as Korea Brain Power Company in 2015. In November 2018, the company was listed on KOSDAQ. In 2020, the company established a branch office in the United States. The core technologies of the company include human antibody libraries, antibody development, and bispecific antibody engineering. These technologies provide therapeutic antibodies for a wide spectrum of indications in oncology, immuno-oncology, ophthalmology, and pulmonology. The company focuses on the development of novel antibody therapeutics. The pipelines of the company include Olinvacimab, PMC-309, PMC-402 and PMC-403.
Who invested in PharmAbcine
17 investors across 6 rounds
See all investors in PharmAbcine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PharmAbcine
Who invested in PharmAbcine?
PharmAbcine has 17 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PharmAbcine raised?
PharmAbcine has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did PharmAbcine last raise money?
PharmAbcine's most recent round on record is a Series G, in Feb 2018.
What does PharmAbcine do?
Based in Daejeon, South Korea, and founded in 2008, PharmAbcine is a specialized biotech company that develops fully human therapeutic monoclonal antibodies (mAb) using innovative discovery technology and excellent human resources for the treatment of human diseases, such as cancer and inflammatory diseases.
Where is PharmAbcine headquartered?
PharmAbcine is headquartered in Daejeon, South Korea.
Which VCs invest in companies like PharmAbcine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at PharmAbcine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series G
Raising like PharmAbcine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.